Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
J Neuroeng Rehabil ; 19(1): 108, 2022 10 08.
Article in English | MEDLINE | ID: covidwho-2064818

ABSTRACT

We diagnosed 66 peripheral nerve injuries in 34 patients who survived severe coronavirus disease 2019 (COVID-19). We combine this new data with published case series re-analyzed here (117 nerve injuries; 58 patients) to provide a comprehensive accounting of lesion sites. The most common are ulnar (25.1%), common fibular (15.8%), sciatic (13.1%), median (9.8%), brachial plexus (8.7%) and radial (8.2%) nerves at sites known to be vulnerable to mechanical loading. Protection of peripheral nerves should be prioritized in the care of COVID-19 patients. To this end, we report proof of concept data of the feasibility for a wearable, wireless pressure sensor to provide real time monitoring in the intensive care unit setting.


Subject(s)
Brachial Plexus , COVID-19 , Peripheral Nerve Injuries , Wearable Electronic Devices , Brachial Plexus/injuries , COVID-19/diagnosis , Feasibility Studies , Humans
2.
J Neurol ; 269(4): 1921-1926, 2022 Apr.
Article in English | MEDLINE | ID: covidwho-1366357

ABSTRACT

INTRODUCTION: Recreational use of nitrous oxide (N2O) is a growing practice in France and all around the world and is often associated with neurological complications. We report detailed clinical and paraclinical presentations of 12 patients with combined degeneration of the spinal cord and peripheral neuropathies in relation to N2O consumption, possibly favored by lockdowns due to SARS-CoV-2 pandemic. RESULTS: With variable levels of consumption, the 12 patients presented spinal cord and/or peripheral nerve damage, with mostly motor and ataxic symptoms, motor axonal nerve damage, and medullary T2-weighted hyperintensities on MRI. There was a clear improvement in symptoms after vitamin B12 substitution, although some sequelae remained, particularly sensory. DISCUSSION: We report detailed clinical, electrophysiological, radiological, and biological consequences of N2O abuse in 12 patients. Our data support the clinical and paraclinical observations reported in the literature. The mechanisms of neurological N2O toxicity are still debated. There is currently no precise recommendation on the therapeutic management. The clinical evolution after vitamin B12 substitution seems sufficient but could depend on early management. Effective messages targeting at risk population, but also the health professionals involved, seem crucial as does a better legal framework for this growing practice.


Subject(s)
COVID-19 , Peripheral Nerve Injuries , Communicable Disease Control , Humans , Nitrous Oxide/adverse effects , Pandemics , SARS-CoV-2 , Vitamin B 12
3.
Am J Trop Med Hyg ; 104(6): 2190-2194, 2021 04 05.
Article in English | MEDLINE | ID: covidwho-1170525

ABSTRACT

Experts have called attention to the possible negative impact of the coronavirus disease 2019 (COVID-19)-related cytokine storm syndrome on the progression of leprosy-related disabilities. We assessed the frequency of reactional states in patients co-infected with Mycobacterium leprae and severe acute respiratory syndrome (SARS) coronavirus (CoV) 2 (SARS-CoV-2). We consecutively included patients during the first peak of the COVID-19 epidemic in Brazil and analyzed the expressions of genes encoding interleukin (IL)-1ß, IL-6, IL-8, IL-10, IL-12A, IL-12B, and tumor necrosis factor-α in peripheral blood mononuclear cells. We included 64 leprosy patients and 50 controls. Twelve of the leprosy patients and 14 of the controls had been diagnosed with COVID-19. Co-infection was associated with increased IL-6 (P = 0.043) and IL-12B (P = 0.017) expression. The median disability grades were higher for leprosy/COVID-19 patients; however, the difference was not significant (P = 0.194). Patients co-infected with M. leprae and SARS-CoV-2 may experience a higher-grade proinflammatory state.


Subject(s)
COVID-19/immunology , Interleukin-12/metabolism , Interleukin-6/metabolism , Leprosy/complications , Peripheral Nerve Injuries/etiology , Adult , COVID-19/complications , COVID-19/metabolism , Cross-Sectional Studies , Female , Gene Expression Regulation/immunology , Humans , Interleukin-12/genetics , Interleukin-6/genetics , Male , Middle Aged , Peripheral Nerve Injuries/metabolism , Peripheral Nerve Injuries/pathology
4.
Ann R Coll Surg Engl ; 103(2): 96-103, 2021 Feb.
Article in English | MEDLINE | ID: covidwho-1073073

ABSTRACT

INTRODUCTION: Adaptation is vital to ensure successful healthcare recovery during the COVID-19 pandemic. Hand trauma represents the most common acute emergency department presentation internationally. This study prospectively evaluates the COVID-19 related patient risk, when undergoing management within one of the largest specialist tertiary referral centres in Europe, which rapidly implemented national COVID-19 safety guidelines. MATERIALS AND METHODS: A prospective cohort study was undertaken in all patients referred to the integrated hand trauma service, during the UK COVID-19 pandemic peak (April-May 2020); all were evaluated for 30-day COVID-19 related death. Random selection was undertaken for patients with hand trauma who either underwent non-operative (control group) or operative (surgery group) management; these groups were prospectively followed-up within a controlled cohort study design and telephoned at 30 days following first intervention (control group) or postoperatively (surgery group). RESULTS: Of 731 referred patients (566 operations), there were no COVID-19 related deaths. Both groups were matched for sex, age, ethnicity, body mass index, comorbidities, smoking, preoperative/first assessment COVID-19 symptoms, pre- and postoperative/first assessment isolation and positive COVID-19 contact (p > 0.050). There were no differences in high service satisfaction (10/10 compared with 10/10; p = 0.067) and treatment outcome (10/10 compared with 10/10; p = 0.961) scores, postoperative/first assessment symptoms (1%, 1/100 compared with 0.8%, 2/250; p = 1.000) or proportion of positive tests (7.1%, 1/14 compared with 2.2%, 2/92; p = 0.349), between the control (n = 100) and surgery (n = 250) groups. CONCLUSION: These data support continued and safe service provision and no increased risk to patients who require surgical management. Such findings are vital for healthcare providers when considering service adaptations to reinstate patient treatment.


Subject(s)
COVID-19/epidemiology , Cross Infection/epidemiology , Hand Injuries/therapy , Surgical Procedures, Operative , Adult , Aged , Amputation, Traumatic/therapy , Case-Control Studies , Cohort Studies , Female , Fractures, Bone/therapy , Hand Injuries/epidemiology , Hand Joints , Humans , Joint Dislocations/therapy , Lacerations/therapy , Male , Middle Aged , Patient Safety , Patient Satisfaction , Peripheral Nerve Injuries/therapy , SARS-CoV-2 , Tendon Injuries/therapy , Tertiary Care Centers , Treatment Outcome , United Kingdom/epidemiology
5.
Radiology ; 298(3): E117-E130, 2021 03.
Article in English | MEDLINE | ID: covidwho-951875

ABSTRACT

With surging numbers of patients with coronavirus disease 2019 (COVID-19) throughout the world, neuromuscular complications and rehabilitation concerns are becoming more apparent. Peripheral nerve injury can occur in patients with COVID-19 secondary to postinfectious inflammatory neuropathy, prone positioning-related stretch and/or compression injury, systemic neuropathy, or nerve entrapment from hematoma. Imaging of peripheral nerves in patients with COVID-19 may help to characterize nerve abnormality, to identify site and severity of nerve damage, and to potentially elucidate mechanisms of injury, thereby aiding the medical diagnosis and decision-making process. This review article aims to provide a first comprehensive summary of the current knowledge of COVID-19 and peripheral nerve imaging.


Subject(s)
COVID-19/complications , Diagnostic Imaging/methods , Peripheral Nerve Injuries/complications , Peripheral Nerve Injuries/diagnostic imaging , Diagnosis, Differential , Humans , Patient Positioning/methods , Peripheral Nerves/diagnostic imaging , SARS-CoV-2
6.
Phys Ther ; 101(1)2021 01 04.
Article in English | MEDLINE | ID: covidwho-883144

ABSTRACT

OBJECTIVE: The use of the prone position to treat patients with COVID-19 pneumonia who are critically ill and mechanically ventilated is well documented. This case series reports the location, severity, and prevalence of focal peripheral nerve injuries involving the upper limb identified in an acute COVID-19 rehabilitation setting. The purpose of this study was to report observations and to explore the challenges in assessing these patients. METHODS: Participants were patients with suspected peripheral nerve injuries following discharge from COVID-19 critical care who were referred to the peripheral nerve injury multidisciplinary team. Data were collected retrospectively on what peripheral neuropathies were observed, with reference to relevant investigation findings and proning history. RESULTS: During the first wave of the COVID-19 pandemic in the United Kingdom, 256 patients were admitted to COVID-19 critical care of Queen Elizabeth Hospital, Birmingham, United Kingdom. From March to June 2020, a total of 114 patients required prone ventilation. In this subgroup, a total of 15 patients were identified with clinical findings of peripheral nerve injuries within the upper limb. In total, 30 anatomical nerve injuries were recorded. The most commonly affected nerve was the ulnar nerve (12/30) followed by the cords of the brachial plexus (10/30). Neuropathic pain and muscle wasting were identified, signifying a high-grade nerve injury. CONCLUSION: Peripheral nerve injuries can be associated with prone positioning on intensive care units, although other mechanisms, such as those of a neuroinflammatory nature, cannot be excluded. IMPACT: Proning-related upper limb peripheral nerve injuries are not discussed widely in the literature and could be an area of further consideration when critical care units review their proning protocols. Physical therapists treating these patients play a key part in the management of this group of patients by optimizing the positioning of patients during proning, making early identification of peripheral nerve injuries, providing rehabilitation interventions, and referring to specialist services if necessary. LAY SUMMARY: During the COVID-19 pandemic, patients who are very ill can be placed for long periods of time on their stomach to improve their chances of survival. The potential consequences of prolonged time in this position are weakness and pain in the arms due to potential nerve damage. There are some recommended treatments to take care of these problems.


Subject(s)
Brachial Plexus Neuropathies/epidemiology , Brachial Plexus/injuries , COVID-19/therapy , Critical Care , Peripheral Nerve Injuries/epidemiology , Adult , Aged , Female , Humans , Male , Middle Aged , Patient Positioning , Retrospective Studies , United Kingdom , Upper Extremity/innervation
7.
J Intensive Care Med ; 35(12): 1576-1582, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-788461

ABSTRACT

INTRODUCTION: Prone positioning is deployed as a critical treatment for improving oxygenation in patients with Acute Respiratory Distress Syndrome. This regimen is currently highly prevalent in the COVID-19 pandemic. The pandemic has brought about increased concern about how best to safely avoid brachial plexus injuries when caring for unconscious proned patients. METHODS: A review of the published literature on brachial plexus injuries secondary to proning ventilated patients was performed. This was combined with a review of available international critical care guidelines in order to produce a succinct set of guidelines to aid critical care departments in reducing brachial plexus injuries during these challenging times. DISCUSSION: There is no one manner in which prone positioning an unconscious patient can be made universally safe. This paper provides 6 key steps to reducing the incidence of brachial plexus injuries while proning and suggests a safe and sensible management and referral pathway for the conscious patient in which a brachial plexus injury is identified. CONCLUSION: There is in truth no completely safe position for every patient and certainly there will be anomalies in anatomy that will predispose certain individuals to nerve injury. Thus the injury rate cannot be reduced to zero but an understanding of the principles of protection will inform those undertaking positioning.


Subject(s)
Brachial Plexus/injuries , Coronavirus Infections/therapy , Patient Positioning/methods , Peripheral Nerve Injuries , Pneumonia, Viral/therapy , Prone Position , Betacoronavirus , COVID-19 , Coronavirus Infections/epidemiology , Critical Care/methods , Humans , Pandemics , Peripheral Nerve Injuries/etiology , Peripheral Nerve Injuries/prevention & control , Pneumonia, Viral/epidemiology , SARS-CoV-2
9.
Can J Neurol Sci ; 48(1): 50-55, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-733558
SELECTION OF CITATIONS
SEARCH DETAIL